Johnson & Johnson announced a settlement on July 27 to resolve talc-related lawsuits alleging ovarian cancer from its baby powder products. The agreement covers approximately 69,000 federal cases in New Jersey plus related state cases, representing 99.75 percent of remaining claims, and requires judicial approval. The exact payment amount is disputed between reports, and all coverage draws from left-center sources only.